Literature DB >> 33653951

Boronic acid with high oxidative stability and utility in biological contexts.

Brian J Graham1, Ian W Windsor1, Brian Gold1, Ronald T Raines2.   

Abstract

Despite their desirable attributes, boronic acids have had a minimal impact in biological contexts. A significant problem has been their oxidative instability. At physiological pH, phenylboronic acid and its boronate esters are oxidized by reactive oxygen species at rates comparable to those of thiols. After considering the mechanism and kinetics of the oxidation reaction, we reasoned that diminishing electron density on boron could enhance oxidative stability. We found that a boralactone, in which a carboxyl group serves as an intramolecular ligand for the boron, increases stability by 104-fold. Computational analyses revealed that the resistance to oxidation arises from diminished stabilization of the p orbital of boron that develops in the rate-limiting transition state of the oxidation reaction. Like simple boronic acids and boronate esters, a boralactone binds covalently and reversibly to 1,2-diols such as those in saccharides. The kinetic stability of its complexes is, however, at least 20-fold greater. A boralactone also binds covalently to a serine side chain in a protein. These attributes confer unprecedented utility upon boralactones in the realms of chemical biology and medicinal chemistry.

Entities:  

Keywords:  bioisosteres; boronic acid; oxidative stability; pharmacophore; stereoelectronic effects

Year:  2021        PMID: 33653951     DOI: 10.1073/pnas.2013691118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  2 in total

1.  Dual-responsive nanoparticles loading bevacizumab and gefitinib for molecular targeted therapy against non-small cell lung cancer.

Authors:  Zi-Tong Zhao; Jue Wang; Lei Fang; Xin-di Qian; Ying Cai; Hai-Qiang Cao; Guan-Ru Wang; Mei-Lin He; Yan-Yan Jiang; Dang-Ge Wang; Ya-Ping Li
Journal:  Acta Pharmacol Sin       Date:  2022-06-15       Impact factor: 6.150

2.  In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking.

Authors:  Luis Heriberto Vázquez-Mendoza; Humberto L Mendoza-Figueroa; Juan Benjamín García-Vázquez; José Correa-Basurto; Jazmín García-Machorro
Journal:  Int J Mol Sci       Date:  2022-04-03       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.